Cengent Therapeutics, Inc.
Records under this name other than patents Cengent Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Cengent Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,498,592 | Display tile structure using organic light emitting materials Formerly held Term ended Term ended May 1, 2019 · USPTO record | Term ended | Term ended May 1, 2019 | USPTO record |
| US 7,392,199 | Diagnosing inapparent diseases from common clinical tests using Bayesian analysis Formerly held Lapsed on the fee record Ended Jun 24, 2016 · USPTO record | Lapsed on the fee record | Ended Jun 24, 2016 | USPTO record |
| US 8,068,993 | Diagnosing inapparent diseases from common clinical tests using Bayesian analysis Formerly held Lapsed on the fee record Ended Nov 29, 2015 · USPTO record | Lapsed on the fee record | Ended Nov 29, 2015 | USPTO record |
| US 7,381,736 | Thiazole and thiadiazole inhibitors of tyrosine phosphatases Formerly held Lapsed on the fee record Ended Jun 3, 2012 · USPTO record | Lapsed on the fee record | Ended Jun 3, 2012 | USPTO record |